BIO-Europe Spring® 2008
As an addition to the varied and in-depth workshops and panels where luminaries cover the business of biotechnology, EBD Group today announced that it will feature a special emphasis on biotech developments in Spain during the BIO-Europe Spring 2008 conference, held April 7-9, 2008 at the Palacio Municipal de Congresos, Madrid.
On Monday, April 7, BIO-Europe Spring will feature a workshop entitled "Focus on Spain", moderated by Mr. Federico Manrique Ruiz, General Director, General Directorate of Technological Innovation, Madrid Regional Ministry of Economy and Consumer Affairs. Panelists will feature Luis Ruiz Ávila, CEO, Advancell; Ignacio González Ochoa, General Director, Biopolis; Pedro M. Franco de Sarabia, President, Biotools B&M Labs.; and Alfonso Casal, Marketing and Sales Director, PharmaMar.
The workshop will showcase four examples of pioneering and established Spanish companies and explain their keys to success Advancell, a world leader in nanomedicine, which is developing a product for the topical treatment of psoriasis and other skin diseases.
Biopolis, a producer of high value products by fermentation of microorganisms with industrial applications in the agri-food and pharma-chemical fields. Biotools B&M Labs, a leader in real-time kits based on its patented Lionprobes technology. PharmaMar, a leading biopharmaceutical company, with five novel compounds committed to advancing the treatment of cancer through the discovery and development of new marine-derived medicines.
Commenting on the fast-evolving Spanish biotechnology industry, Rogelio Pardo, Manager of Madrid Biocluster, stated, "Biotechnology offers interesting business opportunities and is one of the best performing high technology sectors in Spain. The number of companies in Spain with biotechnology related activities is 581, most of which are located in bioregions and bioclusters that foster synergies between these various bio-industry players. Madrid Biocluster, the heart of the Spain's Biotechnology industry, is pleased to welcome BIO-Europe Spring."
According to José Luis Jorcano, President of Genoma España, "The business relevance of the Spanish biotechnology industry is growing very positively. From 2000-2006 the number of biotechnology companies has grown 166%, turnover has increased 200%, and sector employment has grown 750%. Additionally, according to the Spanish Bio-industry association Asebio, the number of Spanish biotechnology alliances has increased in the last two years, and 37% of these alliances have an international partner. The BIO-Europe Spring conference provides a highly visible and unique opportunity for the global biotech community to experience the potential that is the Spanish biotech industry."
write your comments about the article :: © 2008 Exhibition News :: home page